Tag: Paying

Categories
Business

Nikola is paying $8.1 million in authorized charges for ousted chairman Milton

Nikola is paying $8.1 million in legal fees for ousted chairman Milton

Trevor Milton, CEO and Founder of US Nikola, speaks during a presentation of his new all-electric and hydrogen fuel cell battery truck in collaboration with CNH Industrial at an event on December 2, 2019 in Turin, Italy.

Massimo Pinca | Reuters

Competitive electric vehicle startup Nikola is paying $ 8.1 million in legal fees for ousted founder and chairman Trevor Milton, who left the company in September over a short seller fraud case that led to federal investigations.

This helped increase the company’s legal expenses to $ 27.5 million last year. Most of that, $ 24.7 million, was spent answering regulatory investigations and other litigation related to Hindenburg Research’s claims, Nikola said in its annual filing Thursday with the Securities and Exchange Commission.

According to the company, around $ 1.5 million in Milton’s legal fees were paid in 2020. The start-up lost $ 384.3 million last year, including $ 147.1 million in the fourth quarter, it said on Thursday. Adjusted pre-tax loss for 2020 was $ 200.5 million.

As part of the result, Nikola also lowered delivery expectations for its first product, called Tre Semitruck, from 600 this year to 50-100 due to supplier issues. The company’s shares fell at $ 19.72 each during after-hours trading after Thursday’s close Share, down 6.8% for the day.

“The pandemic has caused significant supply chain disruption,” Nikola CEO Mark Russell said during a call for earnings, specifically referring to a shortage of battery cells to power his vehicles.

A Nikola spokeswoman declined to comment on whether the company will attempt to recoup Milton’s legal fees. In his filing, Nikola said the fees were part of his compensation agreement with the company. Additional legal costs are expected this year related to the Hindenburg report, which led to investigations by the SEC and the Justice Department.

“We incurred significant costs due to the regulatory and legal issues surrounding the Hindenburg article,” Nikola said in the filing. “The total cost of these matters will depend on many factors, including the duration of these matters and the determination made.”

Hindenburg accused Milton of making false statements about Nikola’s technology to grow the company and partner with auto companies. The report, titled Nikola: How to Partner an Ocean of Lies with America’s Largest Automaker, was released two days after the announcement of a deal with General Motors that skyrocketed both companies’ shares in September . It characterized Nikola as “an intricate fraud based on dozens of lies” by Milton.

Nikola has denied and denied many of the allegations, but the company confirmed one of Hindenburg’s biggest claims – that it staged a video showing a truck that appeared to be functional but not working.

An internal investigation by Kirkland & Ellis LLP into statements made by Milton and the Company during this period has “substantially been completed”. The Chicago-based law firm has not reached a conclusion whether statements that may have been inaccurate when filed are against any law, the company said.

Categories
Business

Monetary Assist: Grades, Advantage and Speaking to Youngsters About Paying for School

Financial Aid: Grades, Merit and Talking to Kids About Paying for College

If you raise your eyebrows now, admins will feel for you. They also dislike the equity impact of Earnings Aid, even when affluent families receiving $ 20,000 off in many schools can help subsidize low-income families.

However, these enrollment managers also wonder why you are so shocked that they seek Earning Aid in the first place. After all, it’s terribly difficult to fundamentally change the character of a college – its location, the permanent faculty, the types of students who come year after year, what the brand stands for in the entry-level employment market, and 22-year-old law students.

But price? Administrators can change that in no time.

“I get impatient with people who think it’s an easy decision or that schools that do much more merit than we do are somehow morally corrupt,” said Brian Rosenberg, former president of Macalester College in St. Paul, Minn I try to keep their schools open. “

In fact, it’s just a business or something.

“The better the student – and this includes both curriculum choices and grades – the more money will be required to change a student’s choice of enrollment,” said Robert Massa, a longtime administrator of admissions, financial assistance and Communications when he was working at Drew University in New Jersey before becoming a consultant.

But when I pointed out to Mr Massa that it was obvious that students should know how this works – so that they can take harder grades and aim for better grades if they so choose – he winced a little. “Take a heavy load because you want to,” he said. “Not because you think I want you to.”

If this all sounds pretty stressful, know that the experts in the field haven’t quite figured out what they’re going to say to their own children, either. Maureen McRae Goldberg is the former financial assistance director at Occidental College and now has a similar role at Santa Barbara City College. She seemed both resigned and annoyed when I asked what she would say to her daughter when the time comes.

Would it be ridiculous to explain that her high school achievement could be worth a six-figure discount? Is it even fair to bring it up when many schools – especially private colleges – fail to reveal which brand a teenager needs to hit to get any earnings support at all?

“I’m afraid so,” she said. “These are the same questions I’ve been asking for 20 years, and in my naivete I thought we’d fixed some of them now.”

Categories
Health

A European Official Reveals a Secret: The U.S. Is Paying Extra for Coronavirus Vaccines

A European Official Reveals a Secret: The U.S. Is Paying More for Coronavirus Vaccines

This is significantly lower than the company’s official price, which was announced at $ 19.50 per dose, which the US government has also paid. The Pfizer vaccine launch began this week in the United States.

The Moderna vaccine, which is the next to be approved for the EU on January 6 and is expected to receive emergency approval by the U.S. Food and Drug Administration on Friday, costs the EU $ 18 per dose, as the table shows. The company said it would charge $ 25 to $ 37 per dose. The US government was directly involved in funding the development of the Moderna vaccine and has signed a contract to pay around $ 15 per dose.

Covid19 vaccinations>

Answers to your vaccine questions

With a coronavirus vaccine spreading out of the US, here are answers to some questions you may be wondering about:

    • If I live in the US, when can I get the vaccine? While the exact order of vaccine recipients may vary from state to state, most doctors and residents of long-term care facilities will come first. If you want to understand how this decision is made, this article will help.
    • When can I get back to normal life after the vaccination? Life will only get back to normal once society as a whole receives adequate protection against the coronavirus. Once countries have approved a vaccine, they can only vaccinate a few percent of their citizens in the first few months. The unvaccinated majority remain susceptible to infection. A growing number of coronavirus vaccines show robust protection against disease. However, it is also possible that people spread the virus without knowing they are infected because they have mild symptoms or no symptoms at all. Scientists don’t yet know whether the vaccines will also block the transmission of the coronavirus. Even vaccinated people have to wear masks for the time being, avoid the crowds indoors and so on. Once enough people are vaccinated, it becomes very difficult for the coronavirus to find people at risk to become infected. Depending on how quickly we as a society achieve this goal, life could approach a normal state in autumn 2021.
    • Do I still have to wear a mask after the vaccination? Yeah, but not forever. Here’s why. The coronavirus vaccines are injected deep into the muscles and stimulate the immune system to produce antibodies. This seems to be sufficient protection to protect the vaccinated person from disease. What is not clear, however, is whether it is possible for the virus to bloom in the nose – and sneeze or exhale to infect others – even if antibodies have been mobilized elsewhere in the body to prevent that vaccinated person gets sick. The vaccine clinical trials were designed to determine if people who were vaccinated are protected from disease – not to find out if they can still spread the coronavirus. Based on studies of flu vaccines and even patients infected with Covid-19, researchers have reason to hope that people who are vaccinated will not spread the virus, but more research is needed. In the meantime, everyone – including those who have been vaccinated – must imagine themselves as possible silent shakers and continue to wear a mask. Read more here.
    • Will it hurt What are the side effects? The vaccine against Pfizer and BioNTech, like other typical vaccines, is delivered as a shot in the arm. The injection in your arm feels no different than any other vaccine, but the rate of short-lived side effects seems to be higher than with the flu shot. Tens of thousands of people have already received the vaccines, and none of them have reported serious health problems. The side effects, which can be similar to symptoms of Covid-19, last about a day and are more likely to occur after the second dose. Early reports from vaccine trials suggest that some people may need to take a day off because they feel lousy after receiving the second dose. In the Pfizer study, around half developed fatigue. Other side effects occurred in at least 25 to 33 percent of patients, sometimes more, including headache, chills, and muscle pain. While these experiences are not pleasant, they are a good sign that your own immune system is having a strong response to the vaccine that provides lasting immunity.
    • Will mRNA vaccines change my genes? No. Moderna and Pfizer vaccines use a genetic molecule to boost the immune system. This molecule, known as mRNA, is eventually destroyed by the body. The mRNA is packaged in an oily bubble that can fuse with a cell, allowing the molecule to slide inside. The cell uses the mRNA to make proteins from the coronavirus that can stimulate the immune system. At any given moment, each of our cells can contain hundreds of thousands of mRNA molecules that they produce to make their own proteins. As soon as these proteins are made, our cells use special enzymes to break down the mRNA. The mRNA molecules that our cells make can only survive a few minutes. The mRNA in vaccines is engineered to withstand the cell’s enzymes a little longer, so the cells can make extra viral proteins and trigger a stronger immune response. However, the mRNA can hold for a few days at most before it is destroyed.

Eric Mamer, a spokesman for the European Commission, declined to comment on the price list as the negotiated agreements were “kept confidential” but did not contest the pricing.

A spokeswoman for Ms De Bleeker said she tweeted the details to settle a political debate in Belgium in which opposition officials accuse the government of not providing enough money to buy the vaccines.

“We tried to be transparent, but it seems we were a little too transparent,” said Bavo De Mol, the spokesman.

Several health economists have found that the price of the vaccine itself – even if the US is paying more than Europe – is trivial compared to the economic cost of an ongoing pandemic. Just this week, Congress is preparing to approve payments of $ 600 to each American adult to cushion the blow of the pandemic-sparked recession, far more than the $ 39 per person required are to vaccinate adults at the higher Pfizer price.

“The cost of overpayment is so small compared to potential counterfactual factors,” said Benedic Ippolito, an American Enterprise Institute-based researcher who studies drug prices. “It’s like a shrug when our price is a little higher. This is a one-time pandemic and we will deal with the drug price situation later. “

Categories
Business

Why Paying Folks to Be Vaccinated May Backfire

Why Paying People to Be Vaccinated Could Backfire

The approval of the first Covid-19 vaccine in the US was celebrated over the weekend as the beginning of the end of the pandemic. However, the road between giving off the first doses and getting widespread vaccination at rates that inhibit the spread of the coronavirus is far from easy. In addition to the logistical challenges of distributing the vaccine, people also need to be ready to take it. A new poll found that more than a quarter of Americans hesitate.

Two prominent economists, N. Gregory Mankiw and Robert Litan, and politicians John Delaney and Andrew Yang have proposed or supported paying Americans for the vaccine. At first glance, this seems like a reasonable idea; The economy teaches us that people respond to incentives. However, behavioral research suggests that this strategy could backfire.

Humans do not respond to incentives like rats pull levers for food. You are trying to interpret what it means to be offered. In this case, there is a risk that the vaccine will not be a valuable asset.

Studies cited in an article titled “Tom Sawyer and the Construction of Value” (referring to a famous section in the Mark Twain book where Tom convinces his friends that whitewashing a fence is a desirable activity ) have found that people are unsure whether something is good or bad, the prospect of payment helps them make negative decisions.

In one of the studies, a professor asked his students if they would attend a reading of Walt Whitman’s Leaves of Grass, and offered half of the students payment to attend the reading while the other half asked if they would would pay to attend. Those who were offered payment reported less interest in participating. For those who are unsure of whether to get vaccinated, like those who are unsure of whether to attend the poetry reading, paying will most likely send the message that this is something you are not want to do without compensation.

It’s also likely that people will conclude from the payment that the vaccine could be risky. In our research with Kevin Volpp and Alex London, we found that people naturally assume that payments are a risk. In a series of experiments, we have described clinical studies that offered different payment amounts for participating in a study with an unfamiliar test procedure. We found that when the payment was higher, people believed that the risk of a study was greater, even though the descriptions of the study procedures were otherwise identical. Paying people to be vaccinated could also lead them to conclude that it is riskier than they would otherwise assume.

Data so far suggests that Pfizer and Moderna’s early Covid-19 vaccine candidates are safe and effective – evidence that has already led to the Pfizer candidate’s emergency approval. Although direct payments for vaccinations could increase acceptance for some people in the short term, the effects just described could ultimately produce the exact opposite of the intended effects, especially for those unsure whether the risks of vaccination are outweighing the benefits.

Payments not only make the vaccine appear riskier, but they may also reduce the likelihood that people will be vaccinated for the selfless goal of helping others. Research shows that paying people for altruistic measures often backfires. In one study, Israeli students who raised for charity on a given day of the year raised less money than they were paid a small commission.

The report on the study, entitled “Pay Enough or Not Pay at All,” argued that the amount paid was too little to motivate students but enough to ask questions about students’ motives for doing have raised a lot of money in the minds of the people watching these students, and possibly even on the part of the student collectors themselves. The same logic would suggest that paying people for vaccination might decrease the motivation of those who are or like to be altruistic would do.

A more promising approach might be to make desired activities such as travel dependent on vaccination. Australian airline Qantas reports that it and other airlines are considering making vaccination compulsory for international air travel. When vaccination is associated with positive results, such as B. Travel and access to large public events, the vaccination itself is rated positively. When people see the various benefits of vaccination, skepticism will likely go away for at least some.

Ultimately, the circumstances surrounding the introduction of the vaccine can affect attitudes towards it. Given the complexities of making and distributing the vaccine, it is almost certain that it will be in short supply for months. The silver lining is that much research in marketing has shown that scarcity can be a huge demand stimulator. Seeing others want to be vaccinated and desperately waiting to get to the top could increase the likelihood that people will see the value of the vaccine and want it for themselves.

George Loewenstein is the Herbert A. Simon Professor of Economics and Psychology at Carnegie Mellon University. Cynthia Cryder is an Associate Professor of Marketing at Washington University’s Olin Business School in St. Louis.